David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BID
3326
PUT
DELISTED
Sotheby's
BID
| $219K | ﹤0.01% |
5,800
-9,200
| -61% | -$369K |
|
|
EPE
3327
DELISTED
EP Energy Corporation
EPE
| $219K | ﹤0.01% |
839,657
-12,101
| -1% | -$8.02K |
|
3328
Federated Hermes
FHI
$4.85B
| $218K | ﹤0.01% |
+7,433
| New | +$206K |
|
|
AVH
3329
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $218K | ﹤0.01% |
53,286
+17,973
| +51% | +$82.1K |
|
|
DOC
3330
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $218K | ﹤0.01% |
11,615
-208,957
| -95% | -$3.72M |
|
|
SAVE
3331
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $217K | ﹤0.01% |
+4,100
| New | +$236K |
|
3332
PUT
Logitech
LOGI
$14B
| $216K | ﹤0.01% |
+5,500
| New | +$198K |
|
|
AUO
3333
DELISTED
AU Optronics Corp
AUO
| $216K | ﹤0.01% |
59,302
-141,075
| -70% | -$536K |
|
3334
Lindblad Expeditions
LIND
$2.09B
| $215K | ﹤0.01% |
14,077
-19,786
| -58% | -$269K |
|
|
BSTC
3335
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $215K | ﹤0.01% |
3,450
-4,354
| -56% | -$288K |
|
3336
CALL
Deluxe
DLX
$1.09B
| $214K | ﹤0.01% |
+4,900
| New | +$220K |
|
|
PDM
3337
Piedmont Realty Trust
PDM
$1.24B
| $214K | ﹤0.01% |
10,257
-90,350
| -90% | -$1.78M |
|
3338
WEC Energy
WEC
$34.8B
| $214K | ﹤0.01% |
+2,700
| New | +$200K |
|
|
BRG
3339
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $213K | ﹤0.01% |
19,725
+8,325
| +73% | +$86.8K |
|
|
GMS
3340
PUT
DELISTED
GMS Inc
GMS
| $212K | ﹤0.01% |
14,000
-18,500
| -57% | -$334K |
|
3341
CALL
Cheniere Energy
LNG
$57.7B
| $212K | ﹤0.01% |
+3,100
| New | +$204K |
|
|
WLL
3342
DELISTED
Whiting Petroleum Corporation
WLL
| $212K | ﹤0.01% |
108
-1,520
| -93% | -$3.06M |
|
3343
Canadian Solar
CSIQ
$986M
| $210K | ﹤0.01% |
+11,253
| New | +$231K |
|
3344
Oxford Industries
OXM
$544M
| $210K | ﹤0.01% |
+2,794
| New | +$215K |
|
|
CPE
3345
PUT
DELISTED
Callon Petroleum Company
CPE
| $210K | ﹤0.01% |
+2,780
| New | +$215K |
|
3346
CALL
Timken Company
TKR
$8.48B
| $209K | ﹤0.01% |
+4,800
| New | +$204K |
|
3347
L3Harris
LHX
$49B
| $208K | ﹤0.01% |
1,300
-1,400
| -52% | -$216K |
|
3348
CALL
Southwest Airlines
LUV
$19.9B
| $208K | ﹤0.01% |
+4,000
| New | +$211K |
|
3349
Ooma
OOMA
$574M
| $208K | ﹤0.01% |
15,679
-14,089
| -47% | -$212K |
|
3350
NNN REIT
NNN
$8.84B
| $205K | ﹤0.01% |
3,705
-92,203
| -96% | -$4.78M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.